What is the risk of sudden cardiac death in patients presenting with hemodynamically stable sustained ventricular tachycardia after myocardial infarction?

[1]  M Borggrefe,et al.  Benefits of treatment with implantable cardioverter-defibrillators in patients with stable ventricular tachycardia without cardiac arrest. , 1995, British heart journal.

[2]  B. Magnani,et al.  The effect of the angiotensin-converting-enzyme inhibitor zofenopril on mortality and morbidity after anterior myocardial infarction , 1995 .

[3]  A. Woelfel,et al.  Stratification of sudden death risk in patients receiving long-term amiodarone treatment for sustained ventricular tachycardia or ventricular fibrillation. , 1993, The American journal of cardiology.

[4]  E. J. Brown,et al.  Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators. , 1992, The New England journal of medicine.

[5]  J. Langberg,et al.  Survival after implantation of the cardioverter defibrillator. , 1992, The American journal of cardiology.

[6]  R. Hauer,et al.  Determinants of prognosis in symptomatic ventricular tachycardia or ventricular fibrillation late after myocardial infarction. The Dutch Ventricular Tachycardia Study Group of the Interuniversity Cardiology Institute of The Netherlands. , 1990, Journal of the American College of Cardiology.

[7]  P. Denes,et al.  Significance of the clinical presentation in ventricular tachycardia/fibrillation. , 1989, American Heart Journal.

[8]  R. Mulleneers,et al.  The value of the clinical history to assess prognosis of patients with ventricular tachycardia or ventricular fibrillation after myocardial infarction. , 1989, European heart journal.

[9]  R. Winkle,et al.  Long-term outcome with the automatic implantable cardioverter-defibrillator. , 1989, Journal of the American College of Cardiology.

[10]  P. Brugada,et al.  Nonischemic ventricular tachycardia. Clinical course and long-term follow-up in patients without clinically overt heart disease. , 1989, Circulation.

[11]  M. Josephson,et al.  Prognosis following sustained ventricular tachycardia occurring early after myocardial infarction. , 1988, The American journal of cardiology.

[12]  T. Graboys,et al.  Determinants of survival in patients with malignant ventricular arrhythmia associated with coronary artery disease. , 1988, The American journal of cardiology.

[13]  L. Horowitz,et al.  Reduction in sudden death and total mortality by antiarrhythmic therapy evaluated by electrophysiologic drug testing: criteria of efficacy in patients with sustained ventricular tachyarrhythmia. , 1987, Journal of the American College of Cardiology.

[14]  T. D. Sellers,et al.  Sustained ventricular tachyarrhythmias within 2 months of acute myocardial infarction: results of medical and surgical therapy in patients resuscitated from the initial episode. , 1985, Journal of the American College of Cardiology.

[15]  M. Josephson,et al.  Sustained ventricular tachycardia in patients with idiopathic dilated cardiomyopathy: electrophysiologic testing and lack of response to antiarrhythmic drug therapy. , 1984, Circulation.

[16]  M. Josephson,et al.  Role of triple extrastimuli during electrophysiologic study of patients with documented sustained ventricular tachyarrhythmias. , 1984, Circulation.

[17]  R. Winkle,et al.  Determinants of survival in patients with ventricular tachyarrhythmias. , 1983, The New England journal of medicine.

[18]  R. Winkle,et al.  Mortality in patients with implanted automatic defibrillators. , 1983, Annals of internal medicine.

[19]  P. Brugada,et al.  Medical treatment of ventricular tachycardia: considerations in the selection of patients for surgical treatment. , 1982, The American journal of cardiology.